Paper48894
Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
Campbell RW and 5 others. Lancet, 1975. Cited by 89 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Papers, record 48894. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/48894
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arrhythmias, Cardiac | Major topic |
| Mexiletine | Major topic |
| Myocardial Infarction | Major topic |
| Procainamide | Major topic |
| Propylamines | Major topic |
| Administration, Oral | |
| Aged | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Humans | |
| Male | |
| Middle Aged | |
| Placebos | |
| Tachycardia | |
| Ventricular Fibrillation |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39458049 | Comparison of Oral Procainamide and Mexiletine Treatment of Recurrent and Refractory Ventricular Tachyarrhythmias. | J Clin Med | 2024 | https://conductscience.org/library/papers/39458049 | PubMed |
| 36036670 | Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review. | Europace | 2022 | https://conductscience.org/library/papers/36036670 | PubMed |
| 27708780 | Therapeutic drug monitoring of mexiletine at a large academic medical center. | SAGE Open Med | 2016 | https://conductscience.org/library/papers/27708780 | PubMed |
| 10589372 | Clinical pharmacokinetics of mexiletine. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10589372 | PubMed |
| 7126416 | Pharmacokinetics of mexiletine in renal insufficiency. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7126416 | PubMed |
| 3286214 | New antiarrhythmic drugs. | Drugs | 1988 | https://conductscience.org/library/papers/3286214 | PubMed |
| 911569 | Varicella myocarditis presenting with unusual ventricular arrhythmias. | Br Heart J | 1977 | https://conductscience.org/library/papers/911569 | PubMed |
| 687477 | Long-term oral antiarrhythmic therapy with mexiletine. | Br Heart J | 1978 | https://conductscience.org/library/papers/687477 | PubMed |
| 678385 | The clinical pharmacology of mexiletine. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/678385 | PubMed |
| 648399 | Antiarrhythmic drugs: clinical pharmacology and therapeutic uses. | Drugs | 1978 | https://conductscience.org/library/papers/648399 | PubMed |
| 378646 | Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias. | Drugs | 1979 | https://conductscience.org/library/papers/378646 | PubMed |
| 352705 | Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/352705 | PubMed |
| 80219 | Supression of ventricular extrasystoles by perhexiline. | Br Heart J | 1978 | https://conductscience.org/library/papers/80219 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/48894
GET https://conductscience.org/api/papers/v1/48894/authors